Exchange: NASDAQ·Updated 05:46 AM EDT

ARTL Artelo Biosciences Inc

$5.11
$0.24
(4.93%)
Pre-Market
Prev Close $4.87
Mkt Cap$2.97M
Vol30.00

About ARTL

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
33

Bearish Sentiment

How do you feel about ARTL?

Advertisement|Remove ads.